- Oral presentation
- Open Access
O074: EPIPA, a point prevalence survey of urinary, pulmonary and skin infections in 334 French nursing homes
© Vincent et al; licensee BioMed Central Ltd. 2013
- Published: 20 June 2013
- Urinary Tract Infection
- Nursing Home
- Infection Control
- Soft Tissue Infection
- Point Prevalence
Since 2009, nursing homes (NHs) in France have developed their own infection prevention and control programs. Surveillance could help these facilities put in place efficient preventive measures at a local scale.
To provide the participating NHs with baseline data in order to plan future prevention programs.
A point-prevalence survey of urinary tract infections (UTI), respiratory tract infections (RTI) and skin and soft tissues infections (SSTI), as well as a survey about organisation and policies, were undertaken in the NHs of 6 regions in the South-East of France. As a validation study, 10% of the forms collected in a designated region (Rhône-Alpes) were controlled by external healthcare workers (infection control practitioners or nurses).
A total of 334 NHs (28,345 residents) were included in this survey: 80.4% of the NHs (267 out of 332) are developing an infection control program. 58.1% (193/332) of the facilities have an infection control practitioner or infection control nurse (ICT). The proportion of healthcare professionals who have received a specific formation on the prevention of Hospital Acquired Infections (HCAI) was considerably higher in NHs disposing of a part-time ICT than in those without ICT, respectively 72.7% (136/187) and 27.3% (51/187), p<0.001. Among the 28 345 residents who were questioned, 1 262 (4.45%) had at least one UTI, RTI or SSTI. SSTI are the most frequent infection with an overall prevalence of 2.08% (591/28345), followed by RTI - 1.56% (442/28345) - and finally UTI - 1.33% (378/28345). The antimicrobial prevalence was of 3.86% - 1095/28345. Answers to surveys by external ICT yielded 85.6% (95/111) of validations.
This is the first cross-sectional point prevalence study of this importance in France. It was undertaken by the NHs themselves, and the collected data’s quality proves that this methodology is reliable. An impact study is programmed after this first prevalence study in order to assess practical measures which may have been developed and implemented in the NHs based on their prevalence results.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.